Now Reading:

Genentech accepts Roche offer


Genentech accepts Roche offer


Swiss drugmaker Roche has reached a deal with Genentech to acquire all of the shares in the US biotech group that it does not already own.

Over the last nine months Genentech has repeatedly rejected Roche’s attempts to buy the 44 percent of shares saying the price offered undervalued the company. Now Genentech’s board is recommending shareholders accept the latest increased cash offer. Roche is paying the equivalent of 36.5 billion euros.

Every story can be told in many ways: see the perspectives from Euronews journalists in our other language teams.

Next Article